Global Molecular Cytogenetics Markets 2021-2027: Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
June 28, 2021 07:08 ET
|
Research and Markets
Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Molecular...
Global Cytogenetics Market (2020 to 2030) - Key Technologies, Markets & Companies
April 23, 2021 05:58 ET
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Global Molecular Cytogenetics Markets, 2020-2027: Critical Importance of Molecular Biology in Laboratory Processes - Cornerstone for Present & Future Growth
December 02, 2020 08:28 ET
|
Research and Markets
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
October 06, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...
Cytogenetics Market, 2029
September 10, 2020 10:24 ET
|
Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™
August 20, 2020 13:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS...
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
September 26, 2019 10:53 ET
|
Precipio, Inc.
Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO),...
Global Expansion Efforts Begin Yielding Results
July 22, 2019 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that in conjunction with its global expansion efforts, it has begun...
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
June 04, 2019 09:10 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
May 06, 2019 09:20 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...